Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Chung-il Joung"'
Autor:
Dong-Jin Park, Seong-Ho Kim, Seong-Su Nah, Ji Hyun Lee, Seong-Kyu Kim, Yeon-Ah Lee, Seung-Jae Hong, Hyun-Sook Kim, Hye-Soon Lee, Hyoun Ah Kim, Chung-Il Joung, Sang-Hyon Kim, Shin-Seok Lee
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Abstract Background Several lines of evidence imply that brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of fibromyalgia (FM); in this regard, patients with FM have altered blood and cerebrospinal fluid levels of BDNF. In
Externí odkaz:
https://doaj.org/article/50addd8f7de747a19bb6948dccb76d7b
Autor:
Jeong-Won Lee, Kyung-Eun Lee, Dong-Jin Park, Seong-Ho Kim, Seong-Su Nah, Ji Hyun Lee, Seong-Kyu Kim, Yeon-Ah Lee, Seung-Jae Hong, Hyun-Sook Kim, Hye-Soon Lee, Hyoun Ah Kim, Chung-Il Joung, Sang-Hyon Kim, Shin-Seok Lee
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171186 (2017)
Health-related quality of life (HRQOL) in patients with fibromyalgia (FM) is lower than in patients with other chronic diseases and the general population. Although various factors affect HRQOL, no study has examined a structural equation model of HR
Externí odkaz:
https://doaj.org/article/c2b809a94abf47cb9355792eab07c7d6
Autor:
Seong-ji Park, Chung-il Joung, Seung Hyun Cheong, Han Young Ryu, Ga Hyun Lee, Gil Jae Pyo, Mihye Kwon
Publikováno v:
Journal of Rheumatic Diseases. 29:187-189
Autor:
Mihye Kwon, Chung-Il Joung, Hyunah Shin, Sang Min Lee, Chung Chun Lee, Yung Jin Lee, Seonghui Kang, Jong-Yeup Kim, Suehyun Lee
Publikováno v:
SSRN Electronic Journal.
Autor:
Ha-Reum Lee, Sunyoung Lee, In Seol Yoo, Su-Jin Yoo, Mi-Hye Kwon, Chung-il Joung, Ji Ah Park, Seong Wook Kang, Jinhyun Kim
Publikováno v:
Archives of rheumatology. 37(3)
Objectives: This study aims to investigate the role of cluster of differentiation 14 (CD14) expressed monocytes and soluble CD14-mediated pathway in the synovial inflammation of knee osteoarthritis (OA). Patients and methods: Between May 2012 and Jul
Autor:
Seong Wook Kang, Chung-Il Joung, In Seol Yoo, Mihye Kwon, Su-Jin Yoo, Mi-Kyoung Lim, Jinhyun Kim, In Ah Choi
Publikováno v:
Archives of Rheumatology. 34:211-219
Objectives This study aims to examine the possible associations of mitochondrial single nucleotide polymorphisms (SNPs) and Behcet's disease (BD) in a larger patient group. Patients and methods Whole blood or buffy coat was collected from 98 BD patie
Autor:
Ha-Reum Lee, Sunyoung Lee, In Seol Yoo, Su-Jin Yoo, Mi-Hye Kwon, Chung-il Joung, Ji Ah Park, Seong Wook Kang, Jinhyun Kim
Publikováno v:
Archives of Rheumatology; Sep2022, Vol. 37 Issue 3, p335-343, 9p
Autor:
Mihye Kwon, Chung-Il Joung, Seung-Jae Hong, Su-Jin Yoo, Seong Wook Kang, Seung-Cheol Shim, In Seol Yoo, Jinhyun Kim, Sang Wan Chung, Yeon-Ah Lee
Publikováno v:
Scleroderma, myositis and related syndromes.
Background SinceBohan and Peter first described their diagnostic criteria foridiopathic inflammatorymyopathies (IIM) in 1975, new discoveries suchas myositis-specific and myositis-associated autoantibodies (Abs) have been made. Objectives To investig
Autor:
Jinhyun Kim, Seong Wook Kang, Mi Il Kang, Yeon Ah Lee, Sung Hae Chang, In Seol Yoo, In Ah Choi, Seung Jae Hong, Mihye Kwon, Chung Il Joung, Sang Wan Chung
Publikováno v:
Yonsei Medical Journal
Purpose To investigate correlations between myositis-specific autoantibodies (MSA) or myositis-associated antibodies (MAA) and clinical features, thereby demonstrating the utility of clinicoserologic classification in idiopathic inflammatory myopathi
Autor:
S. Won, Seong Su Nah, Soo-Kyung Cho, Young Mo Kang, Young Ok Jung, Won Tae Chung, Jisoo Lee, Choong Ki Lee, Chang Hee Suh, Bo Young Yoon, Wan Hee Yoo, Gwan Gyu Song, Dong Wook Kim, Shin-Seok Lee, Jinseok Kim, Young Joo Kim, Sung Jae Choi, Seung Cheol Shim, H. Koh, Jung Yoon Choe, Yeon Ah Lee, Sang-Hoon Lee, Chung Il Joung, Sang-Heon Lee, Sang Cheol Bae, Hye Soon Lee
Publikováno v:
International Journal of Rheumatic Diseases. 21:1001-1009
To determine characteristics of rheumatoid arthritis (RA) patients in Korea using disease-modifying anti-rheumatic drugs (DMARDs) for at least 6 months, and to identify factors associated with poor health-related outcomes.A total of 2000 RA patients